Kim Seong-Jang, Koo Phillip J, Chang Samuel
Department of Nuclear Medicine, Pusan National University Hospital, Busan, 602-739, Republic of Korea.
Biomedical Research Institute, Pusan National University Hospital, Busan, 602-739, Republic of Korea.
Cancer Chemother Pharmacol. 2016 Apr;77(4):723-31. doi: 10.1007/s00280-016-2988-8. Epub 2016 Feb 18.
The goal of the current study was to investigate the predictive and prognostic values of repeated F-18 FDG PET/CT parameter changes for prediction of complete pathologic response (pCR) in patients with adenocarcinoma of locally advanced esophageal cancer (LAEC) who received preoperative concurrent chemoradiotherapy (PCRT).
A total 53 patients with LAEC patients were included in the current study. All patients were evaluated by F-18 FDG PET/CT before and during chemoradiotherapy. The percent changes (∆, %) in F-18 FDG PET/CT parameters were used to predict pCR and to calculate overall survival (OS). The predictive value for pCR of F-18 FDG PET/CT cutoff values was determined by ROC analysis. The prognostic significance was assessed using Kaplan-Meier analysis.
pCR occurred in 15 patients (28.3 %). When ΔSUVmax > 23.5 % was used as cutoff, the sensitivity and specificity of F-18 FDG PET/CT for prediction of pCR were 100 % and 52.6, respectively. The AUC was 0.750 (95 % CI; 0.612-0.859), and standard error (SE) was 0.0633 (p = 0.0002). ΔMTV resulted in 80 % sensitivity, 76.3 % specificity, and 0.731 AUC (95 % CI; 0.591-0.843, SE = 0.077, p = 0.0027) for cutoff values >25.5 %. When ΔTLG > 44.8 % was used as cutoff, the sensitivity and specificity of F-18 FDG PET/CT for prediction of pCR were 100 and 65.8 %, respectively. The AUC was 0.893 (95 % CI; 0.777-0.961), and SE was 0.0431 (p < 0.0001). Kaplan-Meier analysis showed that high ΔSUVmax, ΔMTV, and ΔTLG were associated with improved OS.
In conclusion, the current study shows the capability of the changes (Δ) in repeated F-18 FDG PET/CT parameters to predict the achievement of pCR during PCRT in LAEC patients. Among the parameters, the ΔSUVmax, ΔMTV, and ΔTLG were predictors for pCR and well associated with OS.
本研究的目的是探讨重复进行的F-18 FDG PET/CT参数变化对接受术前同步放化疗(PCRT)的局部晚期食管癌(LAEC)腺癌患者完全病理缓解(pCR)的预测和预后价值。
本研究共纳入53例LAEC患者。所有患者在放化疗前及放化疗期间均接受F-18 FDG PET/CT评估。F-18 FDG PET/CT参数的百分比变化(∆,%)用于预测pCR并计算总生存期(OS)。通过ROC分析确定F-18 FDG PET/CT临界值对pCR的预测价值。使用Kaplan-Meier分析评估预后意义。
15例患者(28.3%)出现pCR。当以∆SUVmax>23.5%作为临界值时,F-18 FDG PET/CT预测pCR的敏感性和特异性分别为100%和52.6%。曲线下面积(AUC)为0.750(95%置信区间;0.612 - 0.859),标准误差(SE)为0.0633(p = 0.0002)。对于临界值>25.5%,∆MTV的敏感性为80%,特异性为76.3%,AUC为0.731(95%置信区间;0.591 - 0.843,SE = 0.077,p = 0.0027)。当以∆TLG>44.8%作为临界值时,F-18 FDG PET/CT预测pCR的敏感性和特异性分别为100%和65.8%。AUC为0.893(95%置信区间;0.777 - 0.961),SE为0.0431(p < 0.0001)。Kaplan-Meier分析表明,高∆SUVmax、∆MTV和∆TLG与OS改善相关。
总之,本研究表明重复进行的F-18 FDG PET/CT参数变化(∆)能够预测LAEC患者在PCRT期间实现pCR。在这些参数中,∆SUVmax、∆MTV和∆TLG是pCR的预测指标,并与OS密切相关。